TickerFacts.

Incyte Corp (INCY): Net Income

Annual figures by period end, from SEC filings.

$1.29B
Year ended 2025-12-31
$1.43B
Trailing 12 months to 2026-03-31
+55.7%
3-year compound annual growth
2016-12-31: $104.22M2017-12-31: -$313.14M2018-12-31: $109.49M2019-12-31: $446.91M2020-12-31: -$295.70M2021-12-31: $948.58M2022-12-31: $340.66M2023-12-31: $597.60M2024-12-31: $32.62M2025-12-31: $1.29B$1.29B
2016-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$1.29Bn/m2026-02-10, From 2025-01-01
2024-12-31$32.62M-94.5%2026-02-10, From 2024-01-01
2023-12-31$597.60M+75.4%2026-02-10, From 2023-01-01
2022-12-31$340.66M-64.1%2025-02-10, From 2022-01-01
2021-12-31$948.58Mn/m2024-02-13, From 2021-01-01
2020-12-31-$295.70Mn/m2023-02-07, From 2020-01-01
2019-12-31$446.91M+308.2%2022-02-08, From 2019-01-01
2018-12-31$109.49Mn/m2021-02-09, From 2018-01-01
2017-12-31-$313.14Mn/m2020-02-13, From 2017-01-01
2016-12-31$104.22Mn/a2019-02-14, From 2016-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Incyte Corp (INCY)2025-12-31$1.29Bn/m
Charles River Laboratories International, Inc. (CRL)2025-12-27-$142.16Mn/m
Icon PLC (ICLR)2025-12-31$229.34M-69.0%
Medpace Holdings, Inc. (MEDP)2025-12-31$451.12M+11.6%
Iqvia Holdings Inc. (IQV)2025-12-31$1.36B-0.9%
NRC Health (NRC)2025-12-31$11.60M-53.2%
MaxCyte, Inc. (MXCT)2025-12-31-$44.63Mn/m
OmniAb, Inc. (OABI)2025-12-31-$64.78Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$12.43Mn/m

Compare INCY, CRL, ICLR, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗